Novel gene target reveals antidepressant mechanism of electroconvulsive therapy

A study from John Hopkins Medicine (MD, USA) has demonstrated that electroconvulsive therapy (ECT) may aid depression symptoms by acting upon a novel target, the immediate early gene Narp within the hippocampus.

To view restricted content, please:

Register FREE

Login

depression ECT genetics mouse model